Coherus BioSciences
CHRS
#8354
Rank
NZ$0.42 B
Marketcap
NZ$2.74
Share price
-4.40%
Change (1 day)
104.72%
Change (1 year)

Market capitalization of Coherus BioSciences (CHRS)

Market cap: NZ$0.42 Billion

As of May 2026 Coherus BioSciences has a market cap of NZ$0.42 Billion. This makes Coherus BioSciences the world's 8354th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Coherus BioSciences from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.42 B52.42%
2025NZ$0.27 B-8.81%
2024NZ$0.30 B-48.09%
2023NZ$0.58 B-39.56%
2022NZ$0.97 B-45.92%
2021NZ$1.79 B3.38%
2020NZ$1.73 B-7.75%
2019NZ$1.88 B104.14%
2018NZ$0.92 B26.65%
2017NZ$0.72 B-58.98%
2016NZ$1.77 B35.57%
2015NZ$1.30 B88.89%
2014NZ$0.69 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of Coherus BioSciences was reported to be:

NZ$0.44 Billion
by Nasdaq info icon info icon
NZ$0.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$305.51 B 72,113.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$9.81 B 2,219.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.38 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
NZ$10.37 B 2,352.13%๐Ÿ‡บ๐Ÿ‡ธ USA